Influence of elastin-derived peptides on metalloprotease production in endothelial cells

Siemianowicz,Krzysztof; Gminski,Jan; Goss,Malgorzata; Francuz,Tomasz; Likus,Wirginia; Jurczak,Teresa; Garczorz,Wojciech

doi:10.3892/etm.2010.157

Influence of elastin-derived peptides on metalloprotease production in endothelial cells

Authors:
- Krzysztof Siemianowicz
- Jan Gminski
- Malgorzata Goss
- Tomasz Francuz
- Wirginia Likus
- Teresa Jurczak
- Wojciech Garczorz
View Affiliations

Affiliations: Department of Biochemistry, Silesian Medical University, 40-752 Katowice, Poland
Published online on: September 29, 2010 https://doi.org/10.3892/etm.2010.157
Pages: 1057-1060

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Matrix metalloproteases (MMPs) are a family of zinc-dependent endopeptidases that degrade extracellular matrix proteins. MMP-1 and MMP-2 are produced by endothelial cells and are involved in specific vascular pathologies, including atherosclerosis and aortal aneurysm. One of the most important differences between these two metalloproteases is the possibility of hydrolysis of elastin and collagen type IV by MMP-2, but not by MMP-1. Elastin-derived peptides are generated as a result of the degradation of elastin fibers. The aim of our study was to compare the production of MMP-1 and MMP-2 in cultured human arterial endothelial cells derived from vascular pathologies localized at three different sites, the coronary artery, iliac artery and aorta, measured as their concentration in cell culture medium. The second aim was to evaluate the influence of κ-elastin (at concentrations 0.1, 0.4, 1.0, 2.5 or 5.0 µg/ml) on the production of the evaluated metalloproteases in three endothelial cell lines. The production of MMP-1 was statistically significantly greater in endothelial cells derived from the aorta compared to that in the endothelium obtained from the coronary and iliac arteries. There were no statistically significant differences in the production of MMP-2 among the endothelial cell lines tested. The addition of κ-elastin at all evaluated concentrations did not statistically significantly influence the concentration of MMP-1 in the cultured coronary artery endothelium. Furthermore, no statistically significant differences were observed in the cultured iliac artery endothelium. In the cultured endothelium derived from the aorta, κ-elastin at concentrations of 0.1 and 0.4 µg/ml significantly increased the amount of MMP‑1.

View Figures

View References

1.	Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res. 92:827–839. 2003. View Article : Google Scholar : PubMed/NCBI
2.	Nagase H and Woessner JF: Matrix metalloproteases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar
3.	Ross R: Atherosclerosis – an inflammatory disease. N Engl J Med. 340:115–126. 1999.
4.	Palombo D, Maione M, Cifiello BI, Udini M, Maggio D and Lupo M: Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg. 40:257–260. 1999.PubMed/NCBI
5.	Pearce WH and Shively VP: Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann NY Acad Sci. 1085:117–132. 2006. View Article : Google Scholar
6.	Nishimura K, Ikebuchi M, Kanaoka Y, Ohgi S, Ueta E, Nanba E and Ito H: Relationships between matrix metalloproteinases and tissue inhibitors of metalloproteinases in the wall of abdominal aortic aneurysms. Int Angiol. 22:229–238. 2006.PubMed/NCBI
7.	Ishii T and Asuwa N: Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in aortic dissection. Hum Pathol. 31:640–646. 2000. View Article : Google Scholar : PubMed/NCBI
8.	Annabi B, Shedid D, Ghosm P, Kenigsberg RL, Desrosiers RR, Bojanowski MW, Beaulieu E, Nassif E, Moumdjian R and Béliveau R: Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg. 35:539–546. 2002. View Article : Google Scholar : PubMed/NCBI
9.	Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC and Stone NJ; for the Coordinating Committee of the National Cholesterol Education Program: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 44:720–732. 2004. View Article : Google Scholar
10.	Hornebeck W and Robert L: Elastase-like enzymes in aortas and human breast carcinomas: quantitative variations with age and pathology. Adv Exp Med Biol. 79:145–156. 1977. View Article : Google Scholar : PubMed/NCBI
11.	Gminski J and Drozdz M: Succinyl trialanine p-nitroanilide hydrolytic activities in plasma and the aorta of rabbits experimentally immunized with soluble elastin. Exp Pathol. 43:37–40. 1991. View Article : Google Scholar : PubMed/NCBI
12.	Faury G, Ristori MT, Verdetti J, Jacob MP and Robert L: Effect of elastin peptides on vascular tone. J Vasc Res. 32:112–119. 1995. View Article : Google Scholar : PubMed/NCBI
13.	Faury G, Garnier S, Weiss AS, Wallach J, Fülöp T Jr, Jacob MP, Mecham RP, Robert L and Verdetti J: Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca²⁺ level in human vascular endothelial cells. Circ Res. 82:328–336. 1998. View Article : Google Scholar : PubMed/NCBI
14.	Robert L, Labat-Robert J and Robert AM: Genetic, epigenetic and posttranslational mechanisms of aging. Biogerontology. 11:387–399. 2010. View Article : Google Scholar : PubMed/NCBI
15.	Jackson CJ and Nguyen M: Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol. 29:1167–1177. 1997. View Article : Google Scholar
16.	Basu P, Sen U, Tyagi N and Tyagi SC: Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function. Vasc Health Risk Manag. 6:215–228. 2010.PubMed/NCBI
17.	Burridge KA and Friedman MH: Environment and vascular bed origin influence differences in endothelial transcriptional profiles of coronary and iliac arteries. Am J Physiol Heart Circ Physiol. 299:H837–H846. 2010. View Article : Google Scholar : PubMed/NCBI
18.	Aboyans V, Lacroix P and Criqui MH: Large and small vessel atherosclerosis: similarities and differences. Prog Cardiovasc Dis. 50:112–125. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Galis ZS, Sukhova GK, Lark MW and Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of of human atherosclerotic plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar
20.	Feldman LJ, Mazighi M, Scheuble A, Deux JF, De Benedetti E, Badier-Comander C, Brambilla E, Henin D, Steg PG and Jacob MP: Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation. 103:3117–3122. 2001. View Article : Google Scholar
21.	Tummers AM, Mountain DJ, Mix JW, Kirkpatric SS, Cassada DC, Stevens SL, Freeman MB, Goldman MH and Grandas OH: Serum levels of matrix metalloproteinase-2 as a marker of intimal hyperplasia. J Surg Res. 160:9–13. 2010. View Article : Google Scholar : PubMed/NCBI
22.	Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR and Wilkinson IB: Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 25:3722005. View Article : Google Scholar : PubMed/NCBI
23.	Friese RS, Rao F, Khandrika S, Thomas B, Zielgler MG, Schmid-Schönbein GW and O'Connor DT: Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens. 31:521–533. 2009. View Article : Google Scholar : PubMed/NCBI
24.	Qin X, Corriere MA, Matrisian LM and Guzman RJ: Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol. 26:1510–1516. 2006. View Article : Google Scholar : PubMed/NCBI
25.	Kieffer P, Giummelly P, Schjoth B, Carteaux JP, Villemot JP, Hornebeck W and Atkinson J: Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcification. Atherosclerosis. 157:251–254. 2001. View Article : Google Scholar : PubMed/NCBI
26.	Pauly RR, Passaniti A, Bilato C, et al: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 75:41–54. 1994. View Article : Google Scholar
27.	Reeps C, Pelisek J, Seidl S, Schuster T, Zimmermann A, Kuehnl A and Eckstein HH: Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology. 76:243–252. 2009.PubMed/NCBI